Motavizumab, a neutralizing anti-Respiratory Syncytial Virus (Rsv) monoclonal antibody significantly modifies the local and systemic cytokine responses induced by Rsv in the mouse model.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples